Tools & Calculators
Stocks
F&O
Mutual Funds
Nippon India Nifty Pharma ETF
as of 04 May 2026, 14:41 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 21.93% |
| Divi's Laboratories Ltd | Healthcare | E | 9.71% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 9.35% |
| Cipla Ltd | Healthcare | E | 9.04% |
| Lupin Ltd | Healthcare | E | 6.65% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 5.40% |
| Laurus Labs Ltd | Healthcare | E | 4.98% |
| Aurobindo Pharma Ltd | Healthcare | E | 4.07% |
| Alkem Laboratories Ltd | Healthcare | E | 3.93% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 3.84% |
| Biocon Ltd | Healthcare | E | 3.32% |
| Mankind Pharma Ltd | Healthcare | E | 3.03% |
| Zydus Lifesciences Ltd | Healthcare | E | 2.75% |
| Ipca Laboratories Ltd | Healthcare | E | 2.53% |
| J.B. Chemicals & Pharmaceuticals Ltd | Healthcare | E | 2.00% |
| Gland Pharma Ltd | Healthcare | E | 1.73% |
| Abbott India Ltd | Healthcare | E | 1.65% |
| Ajanta Pharma Ltd | Healthcare | E | 1.50% |
| Wockhardt Ltd | Healthcare | E | 1.34% |
| Piramal Pharma Ltd | Healthcare | E | 1.15% |
| Triparty Repo | - | CR | 0.13% |
| Net Current Assets | - | C | 0.05% |
| Cash Margin - Ccil | - | CR | 0.00078% |
| Cash | - | C | 0% |
Equity / Debt / Cash Split
Equity
99.92%
Cash
0.08%
Equity sector allocation
Healthcare
99.92%
Others
0.08%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
32.00%
63.78%
3Y Returns
+63.78%

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.00%
63.78%
3Y Returns
+48.34%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.00%
63.78%
3Y Returns
+45.98%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Jitendra Tolani
Risk Profile
Very High Risk
Expense Ratio
0.21%
Fund Size
₹1058.55 Cr
The Nippon India Nifty Pharma ETF has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 21.93% |
| Divi's Laboratories Ltd | 9.71% |
| Dr Reddy's Laboratories Ltd | 9.35% |
| Cipla Ltd | 9.04% |
| Lupin Ltd | 6.65% |
| Torrent Pharmaceuticals Ltd | 5.40% |
| Laurus Labs Ltd | 4.98% |
| Aurobindo Pharma Ltd | 4.07% |
| Alkem Laboratories Ltd | 3.93% |
| Glenmark Pharmaceuticals Ltd | 3.84% |
| Biocon Ltd | 3.32% |
| Mankind Pharma Ltd | 3.03% |
| Zydus Lifesciences Ltd | 2.75% |
| Ipca Laboratories Ltd | 2.53% |
| J.B. Chemicals & Pharmaceuticals Ltd | 2.00% |
| Gland Pharma Ltd | 1.73% |
| Abbott India Ltd | 1.65% |
| Ajanta Pharma Ltd | 1.50% |
| Wockhardt Ltd | 1.34% |
| Piramal Pharma Ltd | 1.15% |
| Triparty Repo | 0.13% |
| Net Current Assets | 0.05% |
| Cash Margin - Ccil | 0.00% |
| Cash | 0.00% |
The Nippon India Nifty Pharma ETF has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | - |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 99.92% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Nippon India Nifty Pharma ETF:
The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy